An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers.
View / Open Files
Authors
Premi, Enrico
Costa, Tommaso
Gazzina, Stefano
Benussi, Alberto
Cauda, Franco
Gasparotti, Roberto
Archetti, Silvana
Alberici, Antonella
van Swieten, John C
Sanchez-Valle, Raquel
Moreno, Fermin
Santana, Isabel
Laforce, Robert
Ducharme, Simon
Graff, Caroline
Galimberti, Daniela
Masellis, Mario
Tartaglia, Carmela
Rowe, James B
Finger, Elizabeth
Tagliavini, Fabrizio
de Mendonça, Alexandre
Vandenberghe, Rik
Gerhard, Alexander
Butler, Chris R
Danek, Adrian
Synofzik, Matthis
Levin, Johannes
Otto, Markus
Ghidoni, Roberta
Frisoni, Giovanni
Sorbi, Sandro
Peakman, Georgia
Todd, Emily
Bocchetta, Martina
Rohrer, Johnathan D
Borroni, Barbara
GENFI Consortium Members
Publication Date
2022Journal Title
J Alzheimers Dis
ISSN
1387-2877
Publisher
IOS Press
Volume
86
Issue
1
Pages
205-218
Type
Article
This Version
AM
Physical Medium
Print
Metadata
Show full item recordCitation
Premi, E., Costa, T., Gazzina, S., Benussi, A., Cauda, F., Gasparotti, R., Archetti, S., et al. (2022). An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers.. J Alzheimers Dis, 86 (1), 205-218. https://doi.org/10.3233/JAD-215447
Abstract
BACKGROUND: Magnetic resonance imaging (MRI) measures may be used as outcome markers in frontotemporal dementia (FTD). OBJECTIVES: To predict MRI cortical thickness (CT) at follow-up at the single subject level, using brain MRI acquired at baseline in preclinical FTD. METHODS: 84 presymptomatic subjects carrying Granulin mutations underwent MRI scans at baseline and at follow-up (31.2±16.5 months). Multivariate nonlinear mixed-effects model was used for estimating individualized CT at follow-up based on baseline MRI data. The automated user-friendly preGRN-MRI script was coded. RESULTS: Prediction accuracy was high for each considered brain region (i.e., prefrontal region, real CT at follow-up versus predicted CT at follow-up, mean error ≤1.87%). The sample size required to detect a reduction in decline in a 1-year clinical trial was equal to 52 subjects (power = 0.80, alpha = 0.05). CONCLUSION: The preGRN-MRI tool, using baseline MRI measures, was able to predict the expected MRI atrophy at follow-up in presymptomatic subjects carrying GRN mutations with good performances. This tool could be useful in clinical trials, where deviation of CT from the predicted model may be considered an effect of the intervention itself.
Keywords
Frontotemporal dementia, granulin, magnetic resonance imaging, mutation, preclinical, presymptomatic, Atrophy, Brain, Frontotemporal Dementia, Granulins, Humans, Magnetic Resonance Imaging, Mutation, Progranulins
Sponsorship
Medical Research Council (MC_UU_00005/12)
Cambridge University Hospitals NHS Foundation Trust (CUH) (146281)
Medical Research Council (MR/J009482/1)
Medical Research Council (MR/M008983/1)
Medical Research Council (MC_U105597119)
Identifiers
External DOI: https://doi.org/10.3233/JAD-215447
This record's URL: https://www.repository.cam.ac.uk/handle/1810/339501
Statistics
Total file downloads (since January 2020). For more information on metrics see the
IRUS guide.
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: support@repository.cam.ac.uk